Phylogica and Isogenica: Strategic alliance fast tracking screening of drug discovery targets
Phylogica scientists are now confident that using the display technology will ensure accelerated screening of the company’s vast Phylomer libraries to meet demand from potential pharmaceutical partners. Isogenica has been successful in hitting all milestones to date related to the collaboration, which was announced in January 2010.
The objectives of the project were to use Isogenica’s CIS display to achieve further optimisation of Phylogica’s lead compounds targeting CD40 ligand (CD40L).
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.